← Back to Search

My Choices for Alcohol Use Disorder

N/A
Waitlist Available
Led By Joël Tremblay, Ph.D.
Research Sponsored by Université du Québec à Trois-Rivières
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after first interview for the arm ''immediate treatment'' and 6 months after first interview for the group ''waiting list''
Awards & highlights

Study Summary

This trial will compare the alcohol use of people who do and don't do the My Choices - Alcohol program over 3 months.

Eligible Conditions
  • Alcohol Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after first interview for the arm ''immediate treatment'' and 6 months after first interview for the group ''waiting list''
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after first interview for the arm ''immediate treatment'' and 6 months after first interview for the group ''waiting list'' for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in self-reports of alcohol with the time-line follow-back (TLFB) in the last 90 days
Change in the Inventory of consequences associated with alcohol use
Change in the Severity of dependence scale (SDS)
+1 more
Secondary outcome measures
Attention disorder and hyperactivity disorder (ADHD) assesment
Client Satisfaction Questionnaire (CSQ-3)
Confidence to reach the alcohol use goal
+16 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate treatmentExperimental Treatment1 Intervention
The My Choices program will be offered immediately (maximum 10 working days from their first research interview) to the participants of this group. The treatment will be dispensed as usual, wich means there are no special conditions that need to be respected specifically for the study.
Group II: Waiting listActive Control1 Intervention
The My Choices program will be offered 3 months after the first research interview to the participants in this group. The treatment will be dispensed as usual, wich means there are no special conditions that need to be respected specifically for the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
My Choices
2021
N/A
~170

Find a Location

Who is running the clinical trial?

Université du Québec à Trois-RivièresLead Sponsor
42 Previous Clinical Trials
4,216 Total Patients Enrolled
Joël Tremblay, Ph.D.Principal InvestigatorUniversité du Québec à Trois-Rivières

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it still possible to partake in this experiment?

"According to the clinicaltrials.gov registry, this trial is ongoing and actively looking for participants; it was initially posted on October 28th 2021, with its latest update occurring on June 17th 2022."

Answered by AI

What is the scale of enrollment for this trial?

"Affirmative. The clinical trial is actively seeking participants, as evidenced by the data on clinicaltrials.gov which updates that this study was initially posted on October 28th 2021 and revised most recently on June 17th 2022. This medical experiment requires 180 patients to be recruited from 5 distinct sites."

Answered by AI

How many medical facilities are actively testing this treatment protocol?

"Presently, 5 sites are recruiting participants for this medical trial. These include Québec, Jonquière and Lévis amongst a few others; it is thus wise to select the nearest site in order to minimize travel requirements should you decide to join."

Answered by AI

What are the intended outcomes of this trial?

"This study's primary outcome, to be measured within a two week eligibility evaluation period and again three and six months post-initial interview (the first admission was on October 28th with the last anticipated for June 30th), is Change in Short Alcohol Dependance Data Questionnaire (SADD). Secondary outcomes include Satisfaction With Life Domains Scale - 20 questions answered via seven varying facial emoticons representing different levels of sadness or happiness as well as one neutral option; Readiness To Change - 12 inquiries graded from strongly disagree (-2) to strongly agree (2) that measure the participant's willingness to alter their alcohol use habits based off Proch"

Answered by AI
~49 spots leftby Apr 2025